Cisplatin/fluorouracil/pembrolizumab - a regimen consisting of cisplatin, fluorouracil (5-fu) and pembrolizumab that may be used in the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (scchn) and advanced gastric cancer.
Latest articles Cisplatin/fluorouracil/pembrolizumab
|This medical article is a stub. You can help WikiMD by expanding it.|
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Cisplatin/fluorouracil/pembrolizumab for any updates.